Ignite Creation Date:
2024-05-05 @ 10:01 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00005652
Status:
COMPLETED
Last Update Posted:
2008-09-09
First Post:
2000-05-02
Brief Title:
Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura
Sponsor:
University of Alabama at Birmingham
Organization:
Office of Rare Diseases ORD
Organization Data
Organization:
Office of Rare Diseases ORD
Class:
NIH
Study ID:
19915038
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Alabama at Birmingham
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None